Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UBC researcher discovers ’control room’ that regulates immune responses

22.10.2003


The approximately 50 million people in the U.S. who suffer from autoimmune diseases like HIV/AIDS, multiple sclerosis, and arthritis, may soon be able to control their immune responses, thanks to a breakthrough discovery by a researcher at the University of British Columbia in Vancouver, Canada.



Wilfred Jefferies, a professor at UBC’s Biotechnology Laboratory, has discovered and characterized the mechanics of a cellular pathway that triggers immune responses. He and his team have also uncovered a specialized cell substructure, or organelle, that dictates exactly how the immune system will be activated.

"This discovery opens the door to the immune system control room," says Jefferies, who is also a member of UBC’s Biomedical Research Centre. "We’ve found a mechanism that appears to act like a dial – it can turn immune system response up or down."


Jefferies believes that it will take about five years for scientists to use this information to create new therapies – such as medication or vaccines – to regulate immune responses in humans.

The findings have enormous implications for patients because treatment may be targeted by adjusting the "dial", says Jefferies. Immune responses may be increased to fight infection or reduced to help the body accept transplanted tissue or organs.

The work was recently published online in Nature Immunology and will be the topic of an editorial when the journal appears on newsstands in November.

The research findings can be used immediately to test exactly how the immune system responds to a variety of pathogenic organisms, including bacteria, viruses and tumours, says Jefferies, who is a member of UBC’s departments of Microbiology and Immunology, Medical Genetics and Zoology.

Jefferies’ research focuses on dendritic cells. A network of specialized cells, dendritic cells act as sentinels of the immune system, detecting and relaying information about illness-causing organisms or pathogens. Jefferies and his team have identified a new organelle within dendritic cells that sorts pathogens without being harmed by them and controls signals given to the immune system. The signals turn immune responses up or down, according to the type of pathogen encountered.

The immune system protects the body from potentially harmful substances such as microorganisms, toxins, cancer cells, and blood or tissues from another person. Immune system disorders are conditions where the immune response is over-active, reduced or absent.


The research team includes UBC graduate students Greg Lizee, Jacqueline Tiong, Meimei Tian and Kaan Biron as well as post-doctoral fellow Gene Basha. UBC researchers, who conduct more than 5,225 investigations annually, attracted $377 million in research funding in 2002 / 2003.

NB. Editors: Electronic images of Dr. Jefferies as well as dendrite cells are available. A brief biography is attached.

Wilfred Jefferies

Prof. Wilfred Jefferies completed his PhD at Oxford University after obtaining a BSc from University of Victoria in British Columbia.

His completed research training at centres that include Sweden’s Ludwig Institute for Cancer Research, part of the Karolinska Institute, one of Europe’s largest medical universities, as well as at the Swiss Institute for Experimental Cancer Research. In 1989, he was recruited to UBC by the late Michael Smith, 1993 Nobel Laureate in Chemistry.

Jefferies’ work has explored the function of a brain protein called melanotransferrin that plays a key role in iron transport in central nervous system. He and colleagues discovered a link between the action of this molecule and Alzheimer’s disease. Another area of interest is looking at how the immune system detects aggressive cancer cells and how viruses become recognized by host lymphocytes. He has been involved in using TAP genes to resurrect the immune response in patients with metastatic tumours and the development of new tumour vaccines.

The author of numerous publications, Jefferies is funded by major agencies such as the Canadian Institutes of Health Research, the National Cancer Institute of Canada and the Natural Sciences and Engineering Research Council of Canada.

Hilary Thomson | EurekAlert!
Further information:
http://www.ubc.ca/

More articles from Life Sciences:

nachricht Molecular Force Sensors
20.09.2017 | Max-Planck-Institut für Biochemie

nachricht Foster tadpoles trigger parental instinct in poison frogs
20.09.2017 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>